Reply to Suppressive activity of human regulatory T cells is maintained in the presence of TNF.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.International journal of molecular sciences · 2020
   Review
2. Differential roles of TNFα-TNFR1 and TNFα-TNFR2 in the differentiation and function of CD4Cell death & disease · 2019
   Article
3. Targeting Tregs in Juvenile Idiopathic Arthritis and Juvenile Dermatomyositis-Insights From Other Diseases.Frontiers in immunology · 2019
   Review
4. The Effect of TNF-α on Regulatory T Cell Function in Graft-versus-Host Disease.Frontiers in immunology · 2018
   Review
5. Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.Frontiers in immunology · 2018
   Review
6. Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation.Frontiers in immunology · 2017
   Article
7. TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment.Blood · 2016
   Article
8. Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy.Arthritis research & therapy · 2016
   Article
9. Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
   Article

Corrections and comments

• Comment on
  Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis.2013
• Comment on
  Suppressive activity of human regulatory T cells is maintained in the presence of TNF.2016

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as